We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Category:Bio Products > Sera and Vaccines Product Name:Fucoidan CAS No.:/ Standard:In-house Standards Price(USD):0.00 Company:SHANDONG JIEJING GROUP CORPORATION
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Characteristics:
White or light yellow powder, easily soluble in water and forms transparent solution.
Main applications:
1、It can be used as the material of traditional Chinese drugs for kidney disease, obvious effect for early stage of renal failure, especially to improve renal function and increase the kidney on creatinine clearance rate.
2、It can be used in health food and beverage industry. Health food and beverage that contain Fucoidan can carry on the human body immune regulation, improve human body immunity, induce the apoptosis of cancer cells and the generation of cell growth factor, promote all kinds of cells to grow, repair the injured or hypothyroid organs and tissues, reduce the blood fat, blood sugar and cholesterol content, prevent the formation of thrombus.
3、It can be used in cosmetics industry. Fucoidan is an excellent matrix for moisture. The cosmetics can be obviously enhanced the moisturizing effect and repair the injured hypodermal cells if added some certain Fucoidan.
Three years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
